Cholinergic mechanism for intestinal hypermotility caused by arterial occlusion.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001783:Blood Flow Velocity; D004285:Dogs; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007269:Injections, Intra-Arterial; D007422:Intestines / Q000294:innervation*; D008297:Male; D008638:Mesenteric Arteries; D008641:Mesenteric Vascular Occlusion / Q000503:physiopathology*; D010276:Parasympatholytics / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology
D006584:Hexamethonium Compounds; D010276:Parasympatholytics; D010277:Parasympathomimetics; D013779:Tetrodotoxin; D001285:Atropine; D010830:Physostigmine; D010424:Pentobarbital